Table 4

Multivariate Cox regression analysis for OS (n = 52)

EffectHazard ratioLower .95Upper .95P
Age 10 years 0.75 0.43 1.30 .30 
NT-proBNP* 2-fold increase 2.36 1.30 4.30 .005 
cTNT* 2-fold increase 0.99 0.65 1.49 .003 
abs. iFLC 2-fold increase 1.63 1.14 2.34 .008 
Karnofsky index < 80% vs ≥ 80% 5.37 2.04 14.13 < .001 
Kappa/lambda Kappa: lambda 4.69 1.29 17.05 .02 
Heavy chain Yes: no 0.67 0.23 1.96 .47 
Creatinine clearance 10 mL/min increase 0.92 0.76 1.12 .42 
Number of organs 1 additional organ 1.54 0.95 2.50 .08 
EffectHazard ratioLower .95Upper .95P
Age 10 years 0.75 0.43 1.30 .30 
NT-proBNP* 2-fold increase 2.36 1.30 4.30 .005 
cTNT* 2-fold increase 0.99 0.65 1.49 .003 
abs. iFLC 2-fold increase 1.63 1.14 2.34 .008 
Karnofsky index < 80% vs ≥ 80% 5.37 2.04 14.13 < .001 
Kappa/lambda Kappa: lambda 4.69 1.29 17.05 .02 
Heavy chain Yes: no 0.67 0.23 1.96 .47 
Creatinine clearance 10 mL/min increase 0.92 0.76 1.12 .42 
Number of organs 1 additional organ 1.54 0.95 2.50 .08 

abs iFLC indicates absolute involved free light chain concentration; cTNT, cardiac troponin T; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; and OS, overall survival.

*

NT-proBNP and cTNT values did not independently predict for OS (P = .001). Therefore, hazard ratios for these factors were adjusted to the median level of the other factor.

Close Modal

or Create an Account

Close Modal
Close Modal